Cue Biopharma
CUE
CUE
97 hedge funds and large institutions have $241M invested in Cue Biopharma in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 7 closing their positions.
Holders
97
Holders Change
+5
Holders Change %
+5.43%
% of All Funds
1.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
40
Reduced
22
Closed
7
Calls
$359K
Puts
$2.72M
Net Calls
-$2.36M
Net Calls Change
-$2.55M
Top Buyers
| 1 |
CA
1
Corriente Advisors
Fort Worth,
Texas
|
$24M |
| 2 |
2
Morgan Stanley
New York
|
$6.81M |
| 3 |
PM
3
Prosight Management
Dallas,
Texas
|
$11.3M |
| 4 |
4
Millennium Management
New York
|
$4.54M |
| 5 |
5
Goldman Sachs
New York
|
$6.42M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SO
101
STRS Ohio
Columbus,
Ohio
| – | – | -20,500 | Closed |
|
|
AIM
102
Aigen Investment Management
New York
| – | – | -19,705 | Closed |
|
103
SG Americas Securities
New York
| – | – | -16,438 | Closed |
|
|
ASN
104
Advisory Services Network
Atlanta,
Georgia
| – | – | -100 | Closed |
|
|
IA
105
IFP Advisors
Tampa,
Florida
| – | – | – | – |
|
106
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
107
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|